Literature DB >> 17060100

Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma.

Robert D Perel1, Richard E Slaughter, Wendy E Strugnell.   

Abstract

Cardiotoxicity is a well-known consequence of anthracycline chemotherapy. We report CMR findings not previously described in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma. Subendocardial enhancement on late gadolinium contrast-enhanced CMR was present in both cases, with histological correlation in one case.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17060100     DOI： 10.1080/10976640600737664

Source DB:  PubMed          Journal:  J Cardiovasc Magn Reson        ISSN： 1097-6647            Impact factor:   5.364


  8 in total

Review 1.  The emerging clinical role of cardiovascular magnetic resonance imaging.

Authors:  Andreas Kumar; David J Patton; Matthias G Friedrich
Journal:  Can J Cardiol       Date:  2010 Jun-Jul       Impact factor: 5.223

Review 2.  Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.

Authors:  Mohamed Aissiou; Delphine Périé; Farida Cheriet; Nagib S Dahdah; Caroline Laverdière; Daniel Curnier
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-07       Impact factor: 2.357

3.  Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.

Authors:  Brandon C Drafts; Katie M Twomley; Ralph D'Agostino; Julia Lawrence; Nancy Avis; Leslie R Ellis; Vinay Thohan; Jennifer Jordan; Susan A Melin; Frank M Torti; William C Little; Craig A Hamilton; W Gregory Hundley
Journal:  JACC Cardiovasc Imaging       Date:  2013-05-01

4.  Multimodality imaging in the evaluation of cardiovascular manifestations of malignancy.

Authors:  Laura Jiménez-Juan; Jessica Leen; Rachel M Wald; Elsie T Nguyen; Andrew T Yan; Anish Kirpalani; Bernd J Wintersperger; Andrew M Crean
Journal:  Cardiol Res Pract       Date:  2011-03-27       Impact factor: 1.866

5.  Assessment of Subclinical Doxorubicin-induced Cardiotoxicity in a Rat Model by Speckle-Tracking Imaging.

Authors:  Yu Kang; Wei Wang; Hang Zhao; Zhiqing Qiao; Xuedong Shen; Ben He
Journal:  Arq Bras Cardiol       Date:  2017-07-10       Impact factor: 2.000

6.  Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography.

Authors:  Rui Zhao; Fang Shu; Chujie Zhang; Feiyan Song; Yuchen Xu; Ye Guo; Kai Xue; Jinyi Lin; Xianhong Shu; David H Hsi; Leilei Cheng
Journal:  JACC CardioOncol       Date:  2020-03-17

7.  Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.

Authors:  Edythe B Tham; Mark J Haykowsky; Kelvin Chow; Maria Spavor; Sachie Kaneko; Nee S Khoo; Joseph J Pagano; Andrew S Mackie; Richard B Thompson
Journal:  J Cardiovasc Magn Reson       Date:  2013-06-10       Impact factor: 5.364

8.  Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis.

Authors:  Yu Kang; Fei Xiao; Haiyan Chen; Wei Wang; Lijing Shen; Hang Zhao; Xuedong Shen; Fangyuan Chen; Ben He
Journal:  Arq Bras Cardiol       Date:  2018-03       Impact factor: 2.000
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.